跳至主要内容
临床试验/NCT04910438
NCT04910438招募中不适用

Prevalence and Longitudinal Follow-up Over 2 Years of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men (MSM) in Lomé, Togo

ANRS, Emerging Infectious Diseases1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2021年6月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Prevalence at inclusion of anal lesions

研究概览

简要总结

The DepIST-H study, funded by the French AIDS and Hepatitis Research Agency (ANRS), is to estimate prevalence (the number of cases over a given period of time) and incidence (the number of new cases over a given period of time) of anal lesions (condylomas, dysplasia, cancers) by HIV status among MSM in Lomé, Togo

详细描述

Title: Prevalence and longitudinal follow-up over 2 years of anal lesions, HPV infection and associated sexually transmitted infections among men who have sex with men (MSM) in Lomé, Togo (ANRS12400 DepIST-H)

Main objective: To estimate the prevalence and incidence of anal lesions (condyloma, dysplasia and anal cancers) according to HIV status among MSM in Lomé, Togo

Specific objectives :

To estimate the prevalence of HPV infection at baseline (M0) at anal and oropharyngeal sites To describe the persistence of HPV infection at Year 1 and 2 at the anal and oropharyngeal sites To describe the recurrence of anal lesions at Year 1 and 2 To estimate prevalence and incidence of associated STIs (Neisseria gonorrhoeae, Chlamydia trachomatis, Herpes simplex Virus type 2, Mycoplasma genitalium, Trichomonas vaginalis) HBV, HCV and syphilis

Methods :

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Being a male aged 18 or over
  • Self-reporting as being a MSM
  • Wishing to be part of a regular clinical follow-up
  • Agreeing to participate in the study and signing the informed consent form
  • Live in Lomé
  • Having had anal intercourse within the past six months prior to inclusion visit
  • Regardless of HIV status (infected or not)
  • Whether or not the participant has already taken antiretrovirals

排除标准

  • Participation in another biomedical and/or behavioural study on HIV, viral hepatitis or sexually transmitted infections (CohMSM ANRS 12324-EF cohort of Lomé)

结局指标

主要结局

Prevalence at inclusion of anal lesions

时间窗: at Day 0

According to HIV status among MSM in Lomé, Togo

次要结局

  • Incidence of HPV infection(at 12 month and 24 month)
  • Describe the proportion of clearance of HPV infections(at 12 month and 24 month)
  • Describe the number of worsening events of anal cytological lesions(at 12 month and 24 month)
  • Prevalence of anal lesions at baseline(at Day 0)
  • Incidence of anal lesions(at 12 month and 24 month)
  • Prevalence of HPV infections(at Day 0)
  • Describe the proportion of persistent HPV infections(at 12 month and 24 month)
  • Describe the proportion of recurrence of anal lesions(at 12 month and 24 month)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验